Alosetron for irritable bowel syndrome

BMJ. 2002 Sep 14;325(7364):555-6. doi: 10.1136/bmj.325.7364.555.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbolines / therapeutic use*
  • Colonic Diseases, Functional / drug therapy*
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Male

Substances

  • Carbolines
  • Gastrointestinal Agents
  • alosetron